Schizophrenia Clinical Trial
Official title:
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population - An Evaluation Project
Family physicians are the primary health care providers for complex patients such as persons with serious mental illness. The psychiatric needs of these patients could take attention away from management of health problems and from usual health promotion services. For example, Schizophrenia is associated with a higher than normal incidence of diabetes, and first line treatments of Schizophrenia have also been found to increase risk for diabetes. As such, this high-risk group requires targeted diabetes strategies. In London Ontario, services are provided to this high risk mental health population primarily by two community agencies: The Western Ontario Therapeutic Community Hostel (WOTCH) and the Canadian Mental Health Association (CMHA). Accordingly, the goal of this project is to assess how these patients are currently being managed by their family physicians and to pilot a community-based, multidisciplinary diabetes clinic model within this population. If this delivery model proves feasible and effective, family physicians could be assisted by existing community agencies in the management of their patients' diabetes and patients will receive improved access to this vital multidisciplinary team.
In London Ontario, community based services are provided to the high-risk mental health
population by primarily two community agencies: The Western Ontario Therapeutic Community
Hostel (WOTCH) and the Canadian Mental Health Association (CMHA). WOTCH provides treatment,
support, rehabilitation and recovery services to individuals with serious mental illness
including case management, social recreational activities, and vocational and housing
options. Each client is linked to a Community Support Worker who meets with the clients in
their homes or in other community locations to develop rehabilitation plans, monitor the
success of these plans, coordinate services and advocate on the client's behalf. Similarly,
CMHA provides a range of education and support services in the London Middlesex area. CMHA
provides centralized Intake and Assessment for WOTCH, London East Community Mental Health
Services and for their own Community Support Case Management program. The qualifying criteria
for access to the programs are based on assessment of three key elements: Disability,
Duration and Dysfunction.
Collectively WOTCH, CMHA and the London Mental Health Crisis Service maintain a common client
record for clients. Individuals generate crisis plans and information is attained which
includes primary diagnosis, co-morbid health conditions, medication, demographics and family
physician.
Project Population -
Participants in the project were drawn from the active WOTCH and CMHA database. Participants
that were identified in the database as having a diagnosis of Schizophrenia (or Psychotic
Disorder) and/or treatment with a Novel Antipsychotic medication were approached for
participation in the project. Any participants identified in the database with a pre-existing
diagnosis of diabetes were not included in the initial selection of participants. A total of
60 participants meeting the above criteria were selected for the initial screening phase of
the project.
Phase One
The first phase of the proposed project aims to determine how these complex patients were
being managed in primary care. Consent was sought from family physicians that were determined
to be the primary care providers for the participants who met criteria for involvement in the
project. A chart review was conducted on site at each family practice location in a space
provided by the physician. The review includes demographic information, diagnoses, medication
use (past and current), lab results (blood glucose and lipid profile), and a medication side
effects profile.
Phase Two
The second phase of the proposed project aims to quantify the prevalence and risk profile of
diabetes mellitus, as well as mental illness symptomology and disability, in this identified
high-risk population. All participants identified in the chart review as not having received
an Oral Glucose Tolerance Test (OGTT) in the past year, in accordance with current
guidelines, were followed in phase two of the proposed project. In addition, caseworker
feedback was used as a source of information regarding prior screening in cases where
physicians did not consent to participate in the chart audit but the client did consent to
participate. Participants identified as being in need of an OGTT for screening of DM were
invited to attend a screening event held at CMHA or WOTCH facilities. Caseworkers played an
active role in facilitating participants' attendance at the screening events. A phlebotomy
certified staff member conducted the OGTT's. If a lipid profile had not been completed within
the past year, the current sample will also be analyzed for lipids. Diabetes risk profile,
the Brief Symptom Inventory (BSI) and the World Health Organization Disability Scale (WHO-DAS
II) were also completed at this time. The OGTT was sent by the phlebotomist to a major
central lab, contracted by the project, to ensure internal consistency of the analyses.
Copies of the lab results were sent to the family physician, for placement in the
participants' file, and to the data manager, for analyses related to the proposed study.
Phase Three
The third phase of the proposed project aims to evaluate the implementation of a
multidisciplinary model of care, consistent with current guidelines for diabetes management,
within this high-risk population. Participants identified in either of the previous two
phases as having diabetes or pre-diabetes were invited to participate in a multidisciplinary
program for diabetes management. The program runs monthly at identified usual point of WOTCH
and CMHA service locations. Identified WOTCH and CMHA staff are encouraged to attend the
program to serve as a consistent source of progress monitoring and to increase their
knowledge and familiarity with the goals of diabetes management and diabetes complications.
The program is based on the London Intercommunity Health Centre's (LIHC) diabetes risk and
disease management program previously piloted within a Community Health Centre. During the
clinic, participants meet individually with the Nurse Practitioner (NP) who works through a
Diabetes Care Flow Sheet. At each monthly visit, the NP assesses glycemic control,
hypertension, medications, weight, and foot care. Lifestyle counseling is also provided with
respect to smoking, activity, diet and stress. At each participant's initial visit, he or she
is provided with a pedometer and instructed on its use. This aids the NP in assessing
physical activity and provides a motivational tool for the participant. The NP is responsible
for highlighting any variables that fall outside the expected range. If it is decided that
there are issues that need further clinical consultation, the NP then refers the participant
to the appropriate team member. The DHC team includes a foot care specialist, dietician,
Diabetes Education Nurse, and a family physician. The family physician team leader refers any
clinical issues that fall beyond the scope of the DHC for specialist follow up. Each
participant receives appropriate instructions regarding return to the multidisciplinary
clinic.
The NP also monitors each participant's need for periodic lab testing of glucose and lipids.
Annual screening for neuropathy, nephropathy, and eye exams are indicated on the Diabetes
Care Flow Sheet. The DHC team sends participants' family physicians' reminder notices of
these regularly needed referrals as well as any relevant clinical data.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |